Clinical Trials Browser

Phase 1 × Has results × ixabepilone × Clear all

NCT00162136 2020-11-02

Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.

Phase 1 Completed

35 enrolled 17 charts

Solid Malignancies

NCT00832117 2020-10-28

Phase I Combination Ixabepilone + Cisplatin

Phase 1 Completed

30 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Phase 1 Terminated

31 enrolled 12 charts

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT00322374 2016-03-10

Phase I Combination w/ Epirubicin

Phase 1 Completed

42 enrolled 24 charts

Breast Neoplasms

NCT00422097 2016-03-10

A Phase I Study of Oral Ixabepilone in Subjects With Advanced Cancer

Phase 1 Completed

40 enrolled 25 charts

Neoplasms

NCT00568022 2016-03-10

A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer

Phase 1 Completed

9 enrolled 16 charts

Breast Neoplasms

NCT00632424 2016-03-10

Phase 1 Trial of Oral Ixabepilone

Phase 1 Terminated

23 enrolled 11 charts

Other solid neoplasm

Advanced Solid Tumors

NCT00634088 2016-03-10

Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Phase 1 Terminated

13 enrolled 13 charts

Breast Neoplasms